Banner

Corticosteroids Global Market Report 2022 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rhuematology Indications, Endocrinology, Acute Respiratory Diseases), By End User (Hospitals, Clinics, Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 150 | Published : October 2022 | SKU CODE : 7625 | Delivery Time: 2-3 business days | Format :


The corticosteroids therapy market consists of sales of synthetic corticosteroid drugs used to treat a wide variety of disorders, including asthma, arthritis, skin conditions, autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives differ in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are employed at physiological doses for replacement therapy when endogenous production is impaired. The market consists of revenue generated by the company’s manufacturing of synthetic corticosteroids by the sales of these products.

The main product types of corticosteroids therapy are glucocorticoids and mineralocorticoids. Glucocorticoids are a type of corticosteroid hormone that is very effective at suppressing the immune system and reducing inflammation. The therapy is used for the treatment of skin allergies; rhuematology indications; endocrinology; acute respiratory diseases by hospitals; clinics; research institutes; and others.

The corticosteroids therapy market research report is one of a series of new reports from The Business Research Company that provides corticosteroids therapy market statistics, including corticosteroids therapy industry global market size, regional shares, competitors with a corticosteroids therapy market share, detailed corticosteroids therapy market segments, market trends and opportunities, and any further data you may need to thrive in the corticosteroids therapy industry. This corticosteroid therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global corticosteroids market is expected to grow from $4.85 billion in 2021 to $5.05 billion in 2022 at a compound annual growth rate (CAGR) of 4.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The corticosteroid market is expected to reach $5.93 billion in 2026 at a CAGR of 4.1%.

The SARS-CoV outbreak research studies show that corticosteroids as adjunctive therapy may be beneficial to treating corona viruses if utilized in the early acute phase of infection. The use of corticosteroids during the treatment of coronaviruses has shown positive outcomes due to their ability to modulate the inflammatory response. Therefore, the corticosteroids market has experienced a surge in its growth.

The increasing prevalence of Skin related diseases and the rising incidences of rashes, dermatitis, itching, eczema, and psoriasis contributed to the growth of the corticosteroid market. According to the CDC (Center for Disease Control), each year in the US, at least 2 million people are infected with bacteria that are resistant to antibiotics, and at least 23,000 people die due to such infections. According to the European Academy of Dermatology and Venereology report in 2019, of the 2,701 individuals in the survey, at least one skin disorder was found in 1,662 participants (64.5%). Rosacea (25.5%), eczema (11.7%), and Actinic keratosis (26.6%) were the most prominent diagnoses. Skin disorders increased with age and were more prevalent in men (72.3%) than in women (58.0%). The increased prevalence of such disorders increased the demand for corticosteroids, driving the market.

Side effects associated with the long-term use of corticosteroids are negatively affecting the corticosteroids market. More recently, in a meta-analysis that included 28 studies (2,382 patients), the overall risk of adverse events was 150 per 100 patient years. Psychological and behavioral adverse events (e.g., minor mood disturbances) were reported most frequently, followed by gastrointestinal events (e.g., dyspepsia and dysphagia). Infectious complications included bacterial infections; reactivation of tuberculosis or toxoplasmosis; and viral infections, including herpes virus, varicella-zoster virus, and reactivation of viral hepatitis. The association between corticosteroid therapy and subsequent infections was calculated by pooling data from 71 controlled clinical trials. The overall rate of infectious complications was 12.7% in the 2,111 patients randomly allocated to systemic corticosteroids and 8.0% in the 2,087 controls. The risk of infection was particularly high in patients with neurologic diseases and less pronounced in patients with intestinal, hepatic, and renal diseases. The rate was not increased in patients given a daily dose of <10 mg or a cumulative dose of <700 mg of prednisone. With increasing doses, the rate of occurrence of infectious complications increased in patients given corticosteroids as well as in patients given a placebo, a finding suggesting that not only the corticosteroid but also the underlying disease state account for the steroid-associated infectious complications observed in clinical practice. Adverse and unwanted effects due to the use of corticosteroids hurt the corticosteroid market.

The development of silicones for topical and transdermal drug delivery is one of the key trends in the corticosteroid therapy market. Silicone gel sheets are soft wound covers composed of cross-linked polymers reinforced with or bonded to mesh or fabric. A new strategy to deliver drugs to the inner ear from dexamethasone (DXM)-loaded silicone implants and to evaluate the distribution of the drug in the cochlea with confocal microscopy and the development of a new device for local corticosteroids delivery into the oval window with an extended drug release of DXM to the inner ear is also seen in recent years. Silicone gel sheeting is also an excellent treatment option for pediatric patients who may not be able to tolerate intralesional corticosteroid injection. Silicone-based pressure-sensitive adhesives for transdermal drug delivery have shown higher diffusivity and greater skin permeation rate. Silicones offer several advantages such as improved drug permeability, and high diffusivity and offer efficient function and performance to modern drug products.

Sanofi is in talks to buy Flexion Therapeutics. Flexion’s knee injection for osteoarthritis, Zilretta (sustained release corticosteroid), would fit right in with Sanofi’s biosurgery division, which markets its osteoarthritis injectable, Synvisc. Zilretta is a sustained-release corticosteroid first up for approval for use in the knee. Analysts have suggested it could bring in $500 million to $600 million in peak sales and perhaps hit blockbuster status if it wins indications for use in other joints.

Major players in the corticosteroids therapy market are Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca, Cipla, LEO Pharma, Abbott Laboratories, Bayer and Zizhu Pharma.

North America was the largest region in the corticosteroids therapy market in 2021. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the corticosteroids therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the corticosteroids therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The global corticosteroids market is segmented -

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rhuematology Indications, Endocrinology, Acute Respiratory Diseases, Others

3) By End User: Hospitals, Clinics, Research Institutes, Others

    Table Of Contents

    1. Executive Summary

    2. Corticosteroids Therapy Market Characteristics

    3. Corticosteroids Therapy Market Trends And Strategies

    4. Corticosteroids Therapy Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Corticosteroids Therapy Market

    4.2 Ukraine-Russia War Impact On Corticosteroids Therapy Market

    4.3 Impact Of High Inflation On Corticosteroids Therapy Market

    5. Corticosteroids Therapy Market Size And Growth

    5.1. Global Corticosteroids Therapy Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Corticosteroids Therapy Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Corticosteroids Therapy Market Segmentation

    6.1. Global Corticosteroids Therapy Market, Segmentation  By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Glucocorticoids

    Mineralocorticoids

    6.2. Global Corticosteroids Therapy Market, Segmentation  By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Skin Allergies

    Rhuematology Indications

    Endocrinology

    Acute Respiratory Diseases

    Others

    6.3. Global Corticosteroids Therapy Market, Segmentation  By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospitals

    Clinics

    Research Institutes

    Others

    7. Corticosteroids Therapy Market Regional And Country Analysis

    7.1. Global Corticosteroids Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Corticosteroids Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Corticosteroids Therapy Market  

    8.1. Asia-Pacific Corticosteroids Therapy Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Corticosteroids Therapy Market  

    9.1. China Corticosteroids Therapy Market Overview  

    9.2. China Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Corticosteroids Therapy Market  

    10.1. India Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Corticosteroids Therapy Market  

    11.1. Japan Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Corticosteroids Therapy Market  

    12.1. Australia Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Corticosteroids Therapy Market  

    13.1. Indonesia Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Corticosteroids Therapy Market  

    14.1. South Korea Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Corticosteroids Therapy Market  

    15.1. Western Europe Corticosteroids Therapy Market Overview

    15.2. Western Europe Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Corticosteroids Therapy Market  

    16.1. UK Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Corticosteroids Therapy Market  

    17.1. Germany Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Corticosteroids Therapy Market  

    18.3. France Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Corticosteroids Therapy Market  

    19.1. Eastern Europe Corticosteroids Therapy Market Overview

    19.2. Eastern Europe Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Corticosteroids Therapy Market  

    20.1. Russia Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Corticosteroids Therapy Market  

    21.1. North America Corticosteroids Therapy Market Overview

    21.2. North America Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Corticosteroids Therapy Market  

    22.1. USA Corticosteroids Therapy Market Overview

    22.2. USA Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Corticosteroids Therapy Market  

    23.1. South America Corticosteroids Therapy Market Overview

    23.2. South America Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Corticosteroids Therapy Market  

    24.1. Brazil Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Corticosteroids Therapy Market  

    25.1. Middle East Corticosteroids Therapy Market Overview

    25.2. Middle East Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Corticosteroids Therapy Market  

    26.1. Africa Corticosteroids Therapy Market Overview

    26.2. Africa Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Corticosteroids Therapy Market Competitive Landscape And Company Profiles

    27.1. Corticosteroids Therapy Market Competitive Landscape

    27.2. Corticosteroids Therapy Market Company Profiles

    27.2.1. Sumitomo

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Novartis

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Merck

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Sanofi

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Corticosteroids Therapy Pipeline Analysis

    29. Key Mergers And Acquisitions In The Corticosteroids Therapy Market

    30. Corticosteroids Therapy Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Corticosteroids Therapy Market, Segmentation  By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Corticosteroids Therapy Market, Segmentation  By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Corticosteroids Therapy Market, Segmentation  By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Corticosteroids Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Corticosteroids Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: China, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: India, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Japan, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: Australia, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: Indonesia, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: South Korea, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Western Europe, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: UK, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Germany, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: France, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Eastern Europe, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Russia, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: North America, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: USA, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: South America, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Brazil, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Middle East, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Africa, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Sumitomo Financial Performance
  • Table 28: Pfizer Financial Performance
  • Table 29: Novartis Financial Performance
  • Table 30: Merck Financial Performance
  • Table 31: Sanofi Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Corticosteroids Therapy Market, Segmentation  By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Corticosteroids Therapy Market, Segmentation  By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Corticosteroids Therapy Market, Segmentation  By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Corticosteroids Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Corticosteroids Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: China, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: India, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Japan, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: Australia, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: Indonesia, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: South Korea, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Western Europe, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: UK, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Germany, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: France, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Eastern Europe, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Russia, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: North America, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: USA, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: South America, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Brazil, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Middle East, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Africa, Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Sumitomo Financial Performance
  • Figure 28: Pfizer Financial Performance
  • Figure 29: Novartis Financial Performance
  • Figure 30: Merck Financial Performance
  • Figure 31: Sanofi Financial Performance
The Aesthetic Medicine Market Share, Market Size, And Growth Rate 2022
The Leukemia Therapeutics Market Share, Market Size, And Growth Rate 2022
How Will The Medical Foods Market Grow In 2022?
How Will The Filgrastim Biosimilar Market Grow In 2022?
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth
Dermatitis Global Market Report 2022 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Route Of Application (Topical, Oral, Injectable), By Application (Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Immunosuppressants Global Market Report 2022 – By Drug Class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Psoriasis Global Market Report 2022 – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor), By Distribution Channel (Hospitals, Retail Pharmacies, E-Commerce), By Drug Types (Small molecules, Biologics), By Route Of Administration (Oral, Tropical, Injectable), By Disease Indication (Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2022 – By Product Type (Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables), By Application (Endocrinology, Oncology, Cardiology, Therapeutic Drug Development & Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing), By End Users (Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2022 – By Product (Instruments And Devices, Assays And Reagents), By Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests), By Disease Type (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis), By End-User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Respiratory Disposables Global Market Report 2022 – By Type (Masks, Tubes, Inhalers, Other Types), By End User (Hospitals, Clinics, Ambulatory Care Centers, Other End Users), By Disease Indications (Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respiratory Diseases), By Application (Adult, Pediatric & Neonatal) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Radiopharmaceuticals Market 2022 - By Type (Diagnostic, Therapeutic), By Application (Oncology, Cardiology, Neuroendocrinology, Nephrology, Musculoskeletal, Respiratory), By End-User(Hospitals and Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes ), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report